In a remarkable display of market confidence, Intra-Cellular Therapies Inc. (NASDAQ:ITCI) stock has reached an all-time high, touching a price level of $128.01. According to InvestingPro data, the ...

Intra-Cellular Therapies stock opened at $127.01 on Friday. Intra-Cellular Therapies has a twelve month low of $62.78 and a twelve month high of $128.00. The stock has a market cap of $13.50 ...

In this article, we are going to take a look at where Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) stands against the other stocks that dominated last week's rally. Last week saw a strong trading ...

Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) from Outperform to Sector Perform. Analyst Price Forecast Suggests 17.02% ...

Below is Validea's guru fundamental report for INTRA-CELLULAR THERAPIES INC (ITCI). Of the 22 guru strategies we follow, ITCI rates highest using our Value Investor model based on the published ...

In a report released today, Jeffrey Hung from Morgan Stanley maintained a Hold rating on Intra-Cellular Therapies (ITCI – Research Report), ...

Canaccord downgraded Intra-Cellular (ITCI) to Hold from Buy with a price target of $132, up from $119, after Johnson & Johnson (JNJ) agreed ...

Shares of ITCI opened at $127.15 on Wednesday. Intra-Cellular Therapies has a 12 month low of $62.78 and a 12 month high of $128.00. The firm has a fifty day simple moving average of $90.75 and a ...